Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on asymmetric synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107382874A details high-yield synthesis of chiral NHC salts. Enables cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Novel C2 symmetric tetrahydropyrimidine synthesis. High yield, scalable route for asymmetric catalysis intermediates.
Patent CN119552837B reveals high-efficiency enzymatic route for Brivaracetam intermediates, offering superior purity and scalable manufacturing solutions for global supply chains.
Patent CN107311911B reveals a novel chemical route for Niraparib intermediates, replacing costly enzymatic methods with scalable asymmetric synthesis for reliable supply.
Novel non-enzymatic synthesis of niraparib intermediate via oxazolone route. High purity, scalable process offering significant cost reduction in API manufacturing.
Discover the scalable synthesis of CCR-2 antagonist intermediates via patent CN101160286B. Learn about cost-effective routes and high-purity pharmaceutical manufacturing.
Novel asymmetric synthesis patent CN103601701A enables high purity API intermediates with significant cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN115197271B discloses efficient synthesis of chiral selenium/sulfur ligands. Enables cost-effective production of high-purity pharmaceutical intermediates with improved catalytic activity.
Patent CN103755667A reveals a novel organocatalytic route for chiral tetrahydrofurans, offering superior enantioselectivity and scalable manufacturing for global API supply chains.
Novel chiral N-heterocyclic carbene catalyst improves yield and dr value in asymmetric reactions, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN106046065B details a high-yield synthesis of chiral ferrocene ligands. Discover cost-effective manufacturing and reliable supply chain solutions for asymmetric catalysis.
Patent CN106831862A introduces a novel chiral bridged ligand enhancing enantioselectivity in Suzuki reactions, offering cost-effective purification and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN104650022A details a novel Nebivolol synthesis avoiding column chromatography. Enhance supply chain reliability and reduce API manufacturing costs with scalable routes.
Patent CN111471020B reveals a novel Rh-catalyzed route for Avapritinib intermediates, offering safer conditions and reduced costs for reliable API manufacturing.
Novel organocatalytic route offers 99.8% ee. Green scalable process for pharma intermediates. Cost-effective supply chain solution for global buyers.
Patent CN111732542A details a novel synthesis for chiral NN-dioxide ligands featuring axial binaphthyl skeletons, offering enhanced stereocontrol and scalable manufacturing for fine chemical applications.
Patent CN111732542A details a novel chiral ligand synthesis. We offer scalable manufacturing, cost reduction in asymmetric catalysis, and reliable supply chain solutions.
Novel patent CN103880801B offers efficient treprostinil intermediate synthesis reducing cost and enhancing supply chain reliability for pharmaceutical manufacturing.
Novel barbituric acid-based carbon bond catalysts offering superior solubility and efficiency for pharmaceutical intermediate manufacturing.
Novel synthetic route for Sitagliptin avoiding expensive catalysts. High yield, scalable process for pharmaceutical intermediates. Cost-effective manufacturing solution.